Clinical Trial Update: A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing Retosiban to Atosiban in women in spontaneous preterm labor was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstetric Labour Complications
• Preterm Birth

Drugs mentioned

• Atosiban (atosiban)
• Retosiban (retosiban)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Obstetric Labour, Premature | Phase 3 | Status: TERMINATED | Results posted: 2018-09-10